PRU vs SERA · rev $31.19B vs rev $44.0K
PRU (PRU) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
PRU (PRU) common stock.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
Latest reported SERA revenue for 2026-06-30 was $44.0K. Net income was -$17.5M. SERA currently screens at market cap $89.1M.
PRU currently screens at market cap $0. SERA currently screens at market cap $89.1M.
Not investment advice. Open the PRU and SERA stock pages for the full models.
Not investment advice.